Assisted Reproductive Treatment Applications in Men With Normal Phenotype But 45,X/46,Xy Mosaic Karyotype: Clinical and Genetic Perspectives  by Kilic, Sevtap et al.
Taiwan J Obstet Gynecol • June 2010 • Vol 49 • No 2 199
■ CASE REPORT ■
Introduction
Mosaicism is defined as the presence in the same indi-
vidual of two or more cell lines derived from a single
stem cell line but with a different chromosomal consti-
tution. The phenotype of 45,X/46,XY mosaicism is well
recognized in females with gonadal dysgenesis, males
with mixed gonadal dysgenesis, male pseudohermaph-
roditism, and in apparently normal males [1]. Isolated
reports of phenotypically normal females and males with
this disorder have been described, and most present with
ambiguous genitalia and a short stature.
Mosaic 45,X/46,XY individuals are often infertile and
karyotyping can uncover genetic abnormalities. Males
with the mosaic karyotype can benefit from assisted
reproductive therapies, but prenatal diagnosis plays 
an important role in preventing potential transmission
of genetic abnormalities. Because of the increased
incidence of testicular neoplasia (gonadoblastoma) in
patients with X/XY mosaicism, it is important to docu-
ment this chromosomal abnormality [2].
Materials and Methods
Cytogenetic analysis
Metaphase cells were obtained from phytohemagglu-
tinin-stimulated blood lymphocytes from all patients
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using standard techniques. Slides were stained by a
conventional Giemsa-trypsin banding method. Thirty
metaphase spreads were routinely analyzed from each
patient, detecting 10% mosaicism with 95% confidence
[3]. If a second cell line was found, up to 200 meta-
phases were analyzed to establish the level of mosaicism.
Molecular cytogenetic analysis
We collected 2 mL blood samples from male patients
and preserved the samples in EDTA-coated tubes to
analyze microdeletions in the Y chromosome. DNA from
the samples was isolated by a spin column technique.
After DNA isolation, 1.5 μL of MgCl2 (25mM), 0.5 μL
of dNTPs (10mM), 0.2 μL of Taq polymerase, 1 μL
(5μM) of each primer (forward and reverse), 3 μL of
isolated DNA, 15.3 μL of distilled water and 2.3 μL of
phosphate buffered saline were combined for poly-
merase chain reaction. Reactions were carried out on
an automatic thermal cycler and consisted of an initial
denaturation step for 6 minutes at 95°C, followed by
35 cycles of 45 seconds at 94°C, 45 seconds at 58°C,
and 45 seconds at 72°C. After the final cycle, an
extension step for 10 minutes at 72°C was carried out.
Approximately 12 μL of the polymerase chain reaction
product was electrophoresed on a 2% agarose gel and
stained with ethidium bromide to visualize. If a
sequence tagged site from a particular individual failed
to amplify, it was repeated three times before it was
considered to be a deletion.
Case Reports
Case 1
A 28-year-old man was referred to our in vitro fertilization
clinic with male factor infertility. Sperm analysis showed
azoospermia. Phenotypically, he appeared as a normal
male, with a normal penis, scrotum and secondary sex
characteristics. Bilateral testicles were 3 × 3.5 cm in
diameter. In his hormone profile, follicle-stimulating
hormone (FSH) was 21 mIU/mL, luteinizing hormone
(LH) was 16 mIU/mL, and total testosterone was
2.21 ng/mL. Cytogenetic and molecular cytogenetic an-
alyses were performed from peripheral blood. We could
not perform cytogenetic analysis in solid tissues because
of ethical concerns. In total, 100 metaphase spreads
were analyzed. Additionally, 250 cells in the interphase
were evaluated using LSI SRY/CEP X fluorescence in situ
hybridization probes (Abbott Molecular, Abbott Labo-
ratories, Abbott Park, IL, USA) according to the manu-
facturer’s instruction. The level of mosaicism was
determined to be 45X(5%)/46XY(95%) by cytogenetic
analysis, which was concordant with mixed gonadal
dysgenesis. Moreover, Y-chromosome microdeletion an-
alysis revealed deletions in the sY127 and sY134 regions.
Subsequently, the patient underwent bilateral testicu-
lar biopsy. Pathologic examination revealed bilateral
Sertoli cell only and spermatocytic arrest. Sperm could
be obtained from testicular sperm extraction (TESE),
and the young couple were enrolled in an assisted re-
productive technology (ART) program. The possible con-
sequences of ART and the need for prenatal genetic
diagnosis (PGD) or chorionic villus sampling (CVS) were
explained to the couple. Intracytoplasmic sperm injec-
tion was conducted with surgically removed spermato-
zoa, and we achieved three embryos. We planned to
carry out CVS if pregnancy occurred, but unfortunately
this did not happen.
Case 2
A 25-year-old man with normal physical characteris-
tics and primary infertility was found to have severe
oligozoospermia with only a few motile, viable sper-
matozoa in his sperm analysis. His testicular diameters
were 3.2 × 2.5 cm; in his hormone profile, FSH was
26 mIU/mL, LH was 18 mIU/mL, and total testosterone
was 2.8 ng/mL. Cytogenetic and fluorescence in situ
hybridization analysis ascertained 45,X(20%)/46,XY
(80%) mosaicism. The couple was enrolled in an ongo-
ing ART program.
Case 3
A 32-year-old patient presenting with male factor infer-
tility and normal physical appearance, but azoospermia
in his sperm analysis was revealed to have 45,X(45%)/
46,XY(55%) mosaicism in his karyotype analysis. The
FSH value was 23 mIU/mL, LH was 17 mIU/mL, total
testosterone was 2.77 ng/mL, and testicular diameters
were 4.0 × 2.8 cm. We could not obtain any spermato-
zoa by TESE. We carried out a testicular biopsy for
genetic and histologic evaluation. When we examined
peripheral blood and testicular tissue samples for Y-
chromosome microdeletions, the patient exhibited
deletions in sY127 and sY134 of azoospermia factor
(AZF)-b, and sY254 and sY255 of AZFc in blood sam-
ples (Figure). The patient also showed deletions in
sY254 and sY255 of AZFc in testicular tissue samples.
Discussion
The three most common known genetic factors related
to male infertility are cystic fibrosis gene mutations
leading to congenital absence of the vas deferens, Y-
chromosome microdeletions leading to spermatogenic
impairment, and karyotype abnormalities [4].
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The frequency of genetic alterations is increased
among men with severe spermatogenic impairment [5].
A 45X/46XY mosaicism is associated with a broad spec-
trum of phenotypes that include females with Turner
syndrome, males with mixed gonadal dysgenesis, male
pseudohermaphroditism, and apparently normal males
[1]. A normal sized phallus, bilateral scrotal testes and
a lack of evidence of müllerian structures in a pelvic
ultrasound do not rule out the possibility of this chro-
mosomal abnormality [6]. Men with pseudoherma-
phroditism may have penoscrotal, scrotal or perineal
hypospadias as well as bilateral cryptorchidism. Coarc-
tation of aorta, mild mental retardation, cystic hygroma
and spina bifida may be additional clinical features.
The possibility of obtaining a pregnancy from mosaic
and non-mosaic patients with Klinefelter syndrome has
been previously presented [7,8]. These consequences
lead us to a similar possibility for males with aneuploidy.
Hence, in patients with 45X/46XY mosaicism, ART ac-
companied by PGD may result in a successful pregnancy.
Recent studies have shown that aneuploidy rates were
higher in men who had unsuccessful intracytoplasmic
sperm injection outcomes [9]. PGD for aneuploidy is
proposed in reproductive medicine for improving the
clinical outcome following ART. There is substantial
evidence of increased implantation rates and a con-
comitant decrease in spontaneous abortions and ane-
uploidic pregnancies. This condition has severe clinical
consequences, as approximately 33% of spontaneous
abortions are aneuploid.
Foresta et al [10] evaluated 122 infertile, azoosper-
mic men, and cytologic analysis identified Sertoli-cell-
only syndrome, hypospermatogenesis, spermatogonial
and/or spermatocytic arrest, spermatidic arrest, and
normal germ line. Testicular volumes were found to be
reduced in the Sertoli-cell-only, hypospermatogenesis
and spermatogonial and/or spermatocytic arrest group
[10]. However, our patients had normal testicular vol-
umes, and the first patient had both Sertoli cell only and
spermatocytic arrest as found in his testicular biopsy.
In azoospermic subjects, testicular cytologic analysis
permits the identification of different subtypes, and
this classification may be very important in determin-
ing the appropriate therapy, particularly when choos-
ing between surgical treatment and the use of assisted
fertilization techniques by retrieval of epididymal or
intratesticular spermatozoa and spermatids [10].
The Y chromosome is necessary for male germ cell
development. Loss of Y-chromosome sequences in the
euchromatic region of the long arm (Yq) is a major cause
of male infertility. Between 10% and 20% of phenotypi-
cally normal men with idiopathic infertility and an appar-
ently intact Y chromosome carry Yq microdeletions,
resulting in the loss of genes necessary for fertility [11].
The first patient also revealed deletions in the sY127
and sY134 regions through Y-chromosome microdeletion
analysis in addition to 45,X/46,XY mosaicism. Siffroi
et al [12] showed that large and submicroscopic Yq dele-
tions were associated with significantly increased per-
centages of 45,X cells in lymphocytes and of sperm cells
nullisomic for genosomes, especially for the Y chromo-
some. Therefore, Yq microdeletion may be associated
with Y-chromosome instability, leading to the formation
of 45,X cell lines [12].
Case 3 contained AZFb and AZFc microdeletions in
blood samples but exhibited only AZFc microdeletions
in testicular tissue samples. In this case, we could not
obtain any mature spermatozoa. There are few reports
in the literature on this discordance in azoospermic
patients with a 45,X/46,XY mosaic karyotype.
According to a previously published report, men with
a 45,X/46,XY karyotype and malformations of the exter-
nal genitalia are at increased risk of germ cell neoplasia
of the gonads [2]. These tumors have been reported in
subjects with 45,X/46,XY karyotype and gonadal dys-
genesis, as it seems that Y-chromosome material par-
ticipates in gonadoblastoma tumorigenesis. After ART
procedures, gonadectomy can be proposed for patients
who have genital abnormalities like hypospadias and
cryptorchidism.
In conclusion, our cases demonstrate that all men
with azoospermia or severe oligozoospermia should be
evaluated for karyotype and Y-chromosome microdele-
tion analysis, even if they have normal phenotypes. The
chance to obtain sperm in TESE materials and to expe-
rience biologic paternity for these patients should be
kept in mind, but PGD or CVS for possible pregnancies
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Figure. Gel agglutination image from the third patient’s blood
sample with azoospermia factor (AZF)-b (sY127, sY134) and
AZFc (sY254, sY255) Y-chromosome microdeletions and the
testicular sample with AZFc (sY254, sY255) microdeletions in
the Y chromosome. Lane M, 50 bp marker; lane 1, SRY; lane 2,
ZFY; lane 3, control for SRY and ZFY; lane 4, sY84; lane 5,
sY86; lane 6, control for sY84 and sY86; lane 7, sY127; lane 8,
sY134; lane 9, control for sY127 and sY134; lane 10, sY254;
lane 11, sY255; lane 12, control for sY254 and sY255.
should be considered. Moreover, close follow-up for
development of gonadal tumors should be mandatory
in all patients with 45,X/46,XY karyotype and gonadal
dysgenesis.
References
1. Telvi L, Lebbar A, Del Pino O, Barbet JP, Chaussain JL.
45,X/46,XY mosaicism: report of 27 cases. Pediatrics 1999;
104:304–8.
2. Müller J, Ritzén EM, Ivarsson SA, Rajpert-De Meyts E,
Norjavaara E, Skakkebaek NE. Management of males with
45,X/46,XY gonadal dysgenesis. Horm Res 1999;52:11–4.
3. Hook, E. B. Exclusion of chromosomal mosaicism: Tables
of 90%, 95%, and 99% confidence limits and comments on
use. Am J Hum Genet 1977;29:94–7.
4. Kim ED, Bischoff FZ, Lipshultz LkI, Lamb DJ. Genetic con-
cerns for the subfertile male in the era of ICSI. Prenat Diagn
1998;18:1349–65.
5. Niederberger C. Genetic abnormalities among severely
oligospermic men who are candidates for intracytoplasmic
sperm injection. J Urol 2005;174:1046–7.
6. Aranoff GS, Morishima A. XO/XY mosaicism in delayed
puberty. J Adolesc Health Care 1988;9:501–4.
7. Akashi T, Fuse H, Kojima Y, Hayashi M, Honda S. Birth
after intracytoplasmic sperm injection of ejaculated sper-
matozoa from a man with mosaic Klinefelter’s syndrome.
Asian J Androl 2005;7:217–20.
8. Yarali H, Bozdag G. An ongoing pregnancy after frozen
thawed embryo transfer in a patient with Klinefelter’s syn-
drome. Gynecol Obstet Invest 2006;62:165–7.
9. Nicopoullos JD, Gilling-Smith C, Almeida PA, Homa S,
Nice L, Tempest H, Ramsay JW. The role of sperm aneu-
ploidy as a predictor of the success of intracytoplasmic
sperm injection? Hum Reprod 2008;23:240–50.
10. Foresta C, Ferlin A, Bettella A, Rossato M, Varotto A. Diag-
nostic and clinical features in azoospermia. Clin Endocrinol
(Oxf) 1995;43:537–43.
11. Papadimas J, Goulis DG, Giannouli C, Papanicolaou A,
Tarlatzis B, Bontis JN. Ambiguous genitalia, 45,X/46,XY
mosaic karyotype, and Y chromosome microdeletions in a
17-year-old man. Fertil Steril 2001;76:1261–3.
12. Siffroi JP, Le Bourhis C, Krausz C, et al. Sex chromosome
mosaicism in males carrying Y chromosome long arm
deletions. Hum Reprod 2000;15:2559–62.
Taiwan J Obstet Gynecol • June 2010 • Vol 49 • No 2202
S. Kilic, et al
